Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301
Clinical trial NCT05534919 · COMPLETED
Trial details
- NCT number
- NCT05534919
- Sponsor
- Everest Medicines (Singapore) Pte. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-09
- Primary completion
- 2024-07-17
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.